Search results
Showing 131 to 140 of 1323 search results for primary market bulletin.
-
FSA - Primary Market Bulletin No.4: Summary of actions [pdf]
As explained in PMB No. 2, the UKLA Knowledge Base is our new online repository for formal guidance notes, offering practitioners guidance on a number of aspects of the Listing Rules (LR), the Prospectus Rules (PR) and the Disclosure and -
FSA - Primary Market Bulletin No.4: Text amended [pdf]
The listing and prospectus regimes are separate. An issuer who requires its securities to be admitted to the Official List maintained by the UKLA must apply to us for those securities to be listed. The issuer must then meet whichever set of listing -
Policy development update
The policy development update provides some information on our recent and upcoming publications but should not be regarded as comprehensive. -
Primary Market Bulletin 11 - Key amendments [pdf]
Changes made to the technical notes as a result of the feedback received. -
Primary Market Bulletin 12 - Key amendments [pdf]
Changes made to the technical notes as a result of the feedback received. -
FS22/4: ESG integration in UK capital markets
We summarise feedback to our discussion chapter (in CP21/18) on environmental, social and governance (ESG) integration in UK capital markets and set out our potential next steps. -
The retail intermediary market data 2025
This page provides the FCA's analysis of the intermediary sector in 2025 based on data drawn from the Retail Mediation Activities Return (RMAR). -
Primary Market Bulletin 31: Review of delayed disclosure of inside information [pdf]
We have recently undertaken a review of the Delayed Disclosure of Inside Information (DDII) notifications that it receives under Article 17(4) of the Market Abuse Regulation (MAR). -
Primary Market Bulletin 31: Corporate governance disclosures by listed issuers [pdf]
We found several areas where we felt that the corporate governance disclosures required under our rules could be improved -
Regulatory Sandbox accepted firms
Firms that have been accepted into the Regulatory Sandbox, including previous cohorts.